Factor XIII and wound healing;Faktor XIII und wundheilung

Hamostaseologie

Volumn 22, Issue 1, 2002, Pages 45-48

  Wozniak, G ^a   Noll, Th ^a  

^a Knappschaftskrankenhaus Bottrop   (Germany)

Author keywords

Barrier failure; Chronic wound; Tissue regeneration

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A;

BLOOD VESSEL PERMEABILITY; CAPILLARY RESISTANCE; CHRONIC VEIN INSUFFICIENCY; DIABETES MELLITUS; HEALING; PATHOPHYSIOLOGY; POSTTHROMBOSIS SYNDROME; REVIEW; TISSUE REGENERATION; ULCER; WOUND HEALING;

EID: 0036184056     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1622008     Document Type: Review

References (47)

1. Factor XIII in tumor matrix formation and remodelling
2. Factor XIII: A marker of mono- and megakaryocytopoiesis
3. Der wundheilungsprozess aus heutiger sicht
4. Factor XIII and fracture healing
5. Intravital capillaroscopy in patients with chronic venous insufficiency and lyniphoedema: Relevance to Daflon 500 mg
6. Einflüsse des gerinnungs- und fibrinolysesystems auf den wundheilungsprozess und die thrombus-organisation
7. Influences of clotting factors (thrombin, factor XIII) and of fibronectin on the growth of tumor cells and leukemic cells in vitro
8. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
9. Macrophage migration in fibrin gel matrices
10. Factor XIIIa-catalyzed crosslinking of platelet and muscle actin. Regulation by nucleotides
11. Fibrinogen deposition without thrombin generation in primary human breast cancer tissue
12. Calcium-dependent unmasking of active-center cysteine during activation of fibrin stabilizing factor
13. Microcirculation in venous disorders: The role of white blood cells
14. Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation
15. Carcinome bronchioloalvéolaire compliquant une sclérodermie généralisée traitée au long cours par le facteur XIII
16. Interactions of factor XIII with fibrin as substrate and cofactor
17. Primary structure of human coagulation factor XIII
18. The spontaneous course of factor XIII following intracranial hemorrhage: Relevant for re-bleeding?
19. Biosynthesis of plasma factor XIII: Evidence for transcription and translation in hepatoma cells
20. Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy
21. Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis
22. Organization of the gene for human erythrocyte membrane protein 4.2: Structural similarities with the gene for the a subunit of factor XIII
23. Factor Xllla is synthesized and expressed on the surface of U-937 cells and alveolar macrophages
24. Microangiopathy in chronic venous insufficiency
25. Biochemistry of fibrin-stabilizing factor (XIII)
26. Biochemistry of factor XIII and fibrin stabilization
27. Biosynthesis of factor XIII B subunit by human hepatoma cell lines
28. Biosynthesis of factor XIII A and B subunits
29. Endothelzellstimulation dutch AGE - Ein in-vitro-modell diabetischer spätschäden
30. Factor XIIIa and the classic histiocytic markers in malignant fibrous histiocytoma: A comparative immunohistochemical study
31. Effects of factor XIII on endothelial barrier function
32. The lack of attachment of transformed embryonic lung epithelial cells to collagen I is corrected by fibronectin and factor XIII
33. Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies
34. Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses
35. Crosslinking of alpha2-plasmin inhibitor to fibrin by fibrin-stabilizing factor
36. Fibrinogen A alpha and gamma-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease
37. Characterization of cells containing factor XIII subunit a in benign and malignant buccal lesions
38. Phenotypic characterization of macrophage subpopulations and localization of factor XIII in stromal cells of carcinomas
39. Factor XIII in ulcerative leg disease: Background and preliminary clinical results
40. Der einfluss des aktuellen gerinnungsstatus auf das ergebnis der semilokalen rt-PA-lyse bei der distalen zwei-etagen-venenthrombose
41. Behandlung stark sekretierender, chronischer wunden mit faktor XIII: III - Klinische modalitäten und ergebnisse
42. Lokalapplikation von faktor XIII zur therapie cruraler ulcerationen bei patienten mit postthrombotischer anamnese: Klinische bewertung einer pilotuntersuchung
43. Faktor XIII: Experimentelle und klinische ergebnisse beim diabetischen malum perforans
44. Topical treatment of venous ulcer with fibrin stabilizing factor: Experimental investigation of effects on vascular permeability
45. The fibrin-stabilizing factor as a topical means for leg ulcer healing: Biochemical and experimental properties and clinical results
46. Einfluss von faktor XIII auf die endotheliale barriereklinik und experiment